Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 876, pseudogene (RNU6-876P) is a non-coding RNA classified as a pseudogene, specifically related to U6 small nuclear RNA (snRNA), which is an essential component of the spliceosome involved in RNA splicing[1][4]. As a pseudogene, RNU6-876P is not transcribed into a functional product and is generally considered nonfunctional due to the presence of mutations or sequence divergence that prevent normal snRNA function[1][4]. Pseudogenes of snRNAs, like RNU6-876P, may occasionally be transcribed or play regulatory roles through mechanisms such as miRNA sponging, generation of small RNAs, or influencing epigenetic regulation[2], but there is no evidence that RNU6-876P has such functions. It is not a therapeutic target (i.e., not a receptor, enzyme, transporter, or other druggable protein) and is not referenced in the literature as being involved in disease pathogenesis or drug interaction[1][4]. Its presence is primarily a genomic annotation, and it is not considered a protein-coding gene, nor does it have direct clinical or biomarker value.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 876, pseudogene (RNU6-876P).